Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lidocaine Continuous Infusion for ERCP Procedures: a Prospective, Randomized, Double-blinded, Controlled Trial

NCT05274984 is registered in ClinicalTrials.gov with Iuliu Hatieganu University of Medicine and Pharmacy as lead sponsor.

NCT NCT05274984
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05274984 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lidocaine Continuous Infusion for ERCP Procedures: a Prospective, Randomized, Double-blinded, Controlled Trial
Lead sponsor
Iuliu Hatieganu University of Medicine and Pharmacy
Phase
Phase 1
Overall status
Unknown status
Start date
January 3, 2022
Completion date
April 3, 2022
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sedation